Aligos Therapeutics (ALGS) Return on Sales (2021 - 2026)
Aligos Therapeutics (ALGS) reported Return on Sales of 0.08% for Q1 2026, down 147.0% on a YoY basis from 0.17% in Q1 2025, and up 93.08% quarter-over-quarter from 1.18% in Q4 2025.
Aligos Therapeutics (ALGS) Return on Sales (2021 - 2026) Analysis & Trends
Aligos Therapeutics has reported Return on Sales for 6 years, with the latest figure at 0.08% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales fell 147.0% year-over-year to 0.08%; the trailing twelve-month figure through Mar 2026 stood at 0.19% (down 3.0% YoY), and the FY2025 full-year result was 0.11%, up 25.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.08%, up from 1.18% in the prior quarter.
- The five-year high for Return on Sales was 1.39% in Q1 2025, with the low at 1.36% in Q4 2024.
- Historically, Return on Sales has averaged 0.21% across 5 years, with a median of 0.14% in 2022.
- Annual changes were most pronounced in 2025 — Return on Sales jumped 189 bps — and 2026, when it plunged 147 bps.
- Aligos Therapeutics' Return on Sales stood at 0.06% in 2022, then dropped by 18 bps to 0.07% in 2023, then slumped by 1756 bps to 1.36% in 2024, then advanced by 13 bps to 1.18% in 2025, then soared by 93 bps to 0.08% in 2026.
- The last three Return on Sales figures came in at 0.08% (Q1 2026), 1.18% (Q4 2025), and 0.43% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Aligos Therapeutics | 54.72 Mn | -25.11 Mn | - | -0.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.08% |
| Dec 31, 2025 | -1.18% |
| Sep 30, 2025 | -0.43% |
| Jun 30, 2025 | -0.16% |
| Mar 31, 2025 | 1.39% |
| Dec 31, 2024 | -1.36% |
| Sep 30, 2024 | -0.15% |
| Jun 30, 2024 | 0.05% |
| Mar 31, 2024 | -0.50% |
| Dec 31, 2023 | -0.07% |
| Sep 30, 2023 | -0.08% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.09% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -0.38% |
| Jun 30, 2022 | -0.28% |
| Mar 31, 2022 | -0.14% |
| Dec 31, 2021 | -1.03% |
| Sep 30, 2021 | -0.22% |
| Jun 30, 2021 | -0.19% |